PLUS THERAPEUTICS INC (PSTV:NASDAQ)
$4 0 (0%)
Analysed PLUS THERAPEUTICS INC (PSTV:NASDAQ) News Sources
Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
15-05-2026
yahoo.com
Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates
15-05-2026
yahoo.com
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
19-05-2026
yahoo.com
Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
26-05-2026
yahoo.com
Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
04-06-2026
yahoo.com
Plus Therapeutics gains CAP accreditation for CNSide CSF assay platform
04-06-2026
proactiveinvestors.com
Plus Therapeutics to Provide Business Update Call on June 30, 2026
23-06-2026
yahoo.com
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
25-06-2026
yahoo.com
Plus Therapeutics to rebrand as Cerenome and adopt CNSY ticker on August 3 (PSTV)
30-06-2026
advfn.com
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
30-06-2026
stocktwits.com
What is the current price of PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The current price of PLUS THERAPEUTICS INC (PSTV:NASDAQ) is $4.
PLUS THERAPEUTICS INC (PSTV:NASDAQ) absolute price change since previous trading day?
The absolute price change of PLUS THERAPEUTICS INC (PSTV:NASDAQ) since the previous trading day is $0.
PLUS THERAPEUTICS INC (PSTV:NASDAQ) percentage price change since previous trading day?
The percentage price change of PLUS THERAPEUTICS INC (PSTV:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The most recent average sentiment score for PLUS THERAPEUTICS INC (PSTV:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The most recent sentiment for PLUS THERAPEUTICS INC (PSTV:NASDAQ) is .
SEC-8K** Filing Available For PLUS THERAPEUTICS INC (PSTV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.